Interactions of Halichondrin B and Eribulin with Tubulin-Reference-Cited by-同舟云学术

Interactions of Halichondrin B and Eribulin with Tubulin

Published:2011-05-13 Issue:6 Volume:51 Page:1393-1404
ISSN:1549-9596
Container-title:Journal of Chemical Information and Modeling
language:en
Short-container-title:J. Chem. Inf. Model.

Author:

Bai Ruoli,Nguyen Tam Luong¹,Burnett James C.¹,Atasoylu Onur²,Munro Murray H. G.³,Pettit George R.⁴,Smith Amos B.²,Gussio Rick,Hamel Ernest

Affiliation:

1. Target Structure-Based Drug Discovery Group, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland 21702, United States

2. Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States

3. Department of Chemistry, University of Canterbury, Christchurch, New Zealand

4. Department of Chemistry and Biochemistry, Arizona State University, Tempe, Arizona 85287, United States

Publisher

American Chemical Society (ACS)

Subject

Library and Information Sciences,Computer Science Applications,General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ci200077t

Reference43 articles.

1. Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data

2. Comparison of the Activities of the Truncated Halichondrin B Analog NSC 707389 (E7389) with Those of the Parent Compound and a Proposed Binding Site on Tubulin

3. Total synthesis of halichondrin B and norhalichondrin B

4. Synthetic studies on the marine natural product halichondrins

5. Macrocyclic ketone analogues of halichondrin B

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eribulin inhibits tumor growth of two novel patient-derived xenograft models of Merkel cell carcinoma;2024-08-13

2. Development of tubulin polymerization inhibitors as anticancer agents;Expert Opinion on Therapeutic Patents;2023-11-02

3. Microtubule Inhibitors;Holland‐Frei Cancer Medicine;2023-02-20

4. Exploring the Therapeutic Potential of Anticancer Heterocyclic Compounds: Role in Nanoscale Pharmacotherapy;Critical Reviews™ in Therapeutic Drug Carrier Systems;2023

5. The interaction of spongistatin 1 with tubulin;Archives of Biochemistry and Biophysics;2022-09